How nicotine levels in e-cigarettes affect smoking behavior and health in African American and White smokers
Impact of e-cigarette nicotine concentration on compensation, cigarette use, and biomarkers of exposure and harm in African American and White smokers
This study is looking at how different amounts of nicotine in e-cigarettes affect the smoking habits and health of African American and White smokers, so we can better understand any health differences and help improve e-cigarette regulations.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10911239 on NIH RePORTER |
What this research studies
This research investigates how different concentrations of nicotine in e-cigarettes influence smoking behaviors and health outcomes among African American and White smokers. It aims to understand the compensatory puffing patterns and exposure to harmful substances based on nicotine levels in e-liquids. By comparing the smoking habits of these two groups, the study seeks to identify potential health disparities and inform regulatory standards for e-cigarette products. Participants will provide data on their smoking habits and biological markers of exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American and White smokers aged 21 and older who use e-cigarettes.
Not a fit: Patients who do not smoke or use e-cigarettes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better regulations on e-cigarette nicotine levels, ultimately reducing health risks for smokers.
How similar studies have performed: While there is emerging research on e-cigarette use, this specific investigation into nicotine concentration effects among different racial groups is relatively novel.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Leavens, Eleanor Ladd Schneider — University of Kansas Medical Center
- Study coordinator: Leavens, Eleanor Ladd Schneider
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.